These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31915365)
41. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089 [TBL] [Abstract][Full Text] [Related]
43. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation. Dogaru M; Lazăr V; Coriu D Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807 [TBL] [Abstract][Full Text] [Related]
44. Analytical issues of serum free light chain assays and the relative performance of polyclonal and monoclonal based reagents. Carr-Smith HD; Jenner EL; Evans JA; Harding SJ Clin Chem Lab Med; 2016 Jun; 54(6):997-1003. PubMed ID: 26943608 [TBL] [Abstract][Full Text] [Related]
45. Is accuracy of serum free light chain measurement achievable? Jacobs JF; Tate JR; Merlini G Clin Chem Lab Med; 2016 Jun; 54(6):1021-30. PubMed ID: 26641970 [TBL] [Abstract][Full Text] [Related]
46. Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study. Yadav P; Sathick IJ; Leung N; Brown EE; Cook M; Sanders PW; Cockwell P Blood Cancer J; 2020 Mar; 10(3):28. PubMed ID: 32127527 [TBL] [Abstract][Full Text] [Related]
47. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications. Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013 [TBL] [Abstract][Full Text] [Related]
49. Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports. Gagliardi A; Carbone C; Russo A; Cuccurullo R; Lucania A; Cioppa PD; Misso G; Caraglia M; Tommasino C; Mastrullo L Oncol Lett; 2016 Oct; 12(4):2363-2370. PubMed ID: 27698801 [TBL] [Abstract][Full Text] [Related]
50. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment. Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509 [TBL] [Abstract][Full Text] [Related]
51. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695 [TBL] [Abstract][Full Text] [Related]
52. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy. Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775 [TBL] [Abstract][Full Text] [Related]
53. The evolving use of serum free light chain assays in haematology. Pratt G Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis. Mollee P; Tate J; Pretorius CJ Clin Chem Lab Med; 2013 Dec; 51(12):2303-10. PubMed ID: 23934643 [TBL] [Abstract][Full Text] [Related]
55. Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal Insufficiency. Xu L; Zhao B; Sun Y; Wang S; Chen X; Mao Y Biomed Res Int; 2022; 2022():5536199. PubMed ID: 35392256 [TBL] [Abstract][Full Text] [Related]
56. Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease. Yang Y; Han X; Zheng G; Cai Z Health Sci Rep; 2019 Apr; 2(4):e113. PubMed ID: 31049418 [TBL] [Abstract][Full Text] [Related]
57. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920 [TBL] [Abstract][Full Text] [Related]
58. Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies. Cigliana G; Torti E; Gulli F; De Santis E; Dell'Abate MT; Colacicco L; Pisani F; Conti L; Basile U J Exp Clin Cancer Res; 2015 Apr; 34(1):37. PubMed ID: 26025441 [TBL] [Abstract][Full Text] [Related]
59. Detection of monoclonal free light chains by immunofixation electrophoresis and isoelectric focusing - comparison with the quantitative method of determination. Kušnierová P; Zeman D; Revendová K; Dlouhý O Scand J Clin Lab Invest; 2020 Nov; 80(7):556-561. PubMed ID: 32779491 [TBL] [Abstract][Full Text] [Related]
60. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy]. Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]